Intrinsic value of Aceto - ACET

Previous Close

$15.25

  Intrinsic Value

$46.73

stock screener

  Rating & Target

str. buy

+206%

  Value-price divergence*

+33%

Previous close

$15.25

 
Intrinsic value

$46.73

 
Up/down potential

+206%

 
Rating

str. buy

 
Value-price divergence*

+33%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of ACET stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.19
  20.30
  18.77
  17.39
  16.15
  15.04
  14.03
  13.13
  12.32
  11.59
  10.93
  10.33
  9.80
  9.32
  8.89
  8.50
  8.15
  7.84
  7.55
  7.30
  7.07
  6.86
  6.67
  6.51
  6.36
  6.22
  6.10
  5.99
  5.89
  5.80
  5.72
Revenue, $m
  559
  672
  799
  938
  1,089
  1,253
  1,429
  1,616
  1,815
  2,026
  2,247
  2,479
  2,722
  2,976
  3,241
  3,516
  3,803
  4,101
  4,410
  4,732
  5,066
  5,414
  5,775
  6,151
  6,542
  6,949
  7,373
  7,814
  8,275
  8,755
  9,255
Variable operating expenses, $m
 
  559
  663
  777
  902
  1,036
  1,181
  1,335
  1,499
  1,672
  1,854
  2,038
  2,237
  2,446
  2,663
  2,890
  3,125
  3,370
  3,624
  3,889
  4,164
  4,449
  4,746
  5,055
  5,377
  5,711
  6,059
  6,422
  6,800
  7,195
  7,606
Fixed operating expenses, $m
 
  37
  38
  39
  40
  41
  42
  43
  44
  45
  46
  47
  48
  50
  51
  52
  53
  55
  56
  58
  59
  60
  62
  64
  65
  67
  68
  70
  72
  74
  76
Total operating expenses, $m
  501
  596
  701
  816
  942
  1,077
  1,223
  1,378
  1,543
  1,717
  1,900
  2,085
  2,285
  2,496
  2,714
  2,942
  3,178
  3,425
  3,680
  3,947
  4,223
  4,509
  4,808
  5,119
  5,442
  5,778
  6,127
  6,492
  6,872
  7,269
  7,682
Operating income, $m
  58
  76
  98
  121
  147
  176
  206
  238
  273
  309
  347
  394
  437
  481
  526
  574
  624
  676
  730
  786
  844
  904
  967
  1,032
  1,100
  1,171
  1,245
  1,322
  1,402
  1,486
  1,573
EBITDA, $m
  71
  92
  115
  141
  169
  199
  232
  266
  303
  343
  384
  427
  472
  520
  569
  621
  674
  730
  788
  848
  910
  975
  1,043
  1,113
  1,186
  1,263
  1,342
  1,425
  1,511
  1,601
  1,695
Interest expense (income), $m
  3
  4
  6
  8
  10
  12
  14
  17
  20
  23
  26
  29
  33
  36
  40
  44
  48
  52
  57
  61
  66
  71
  76
  82
  87
  93
  99
  105
  112
  119
  126
Earnings before tax, $m
  54
  72
  92
  114
  138
  164
  192
  221
  253
  286
  322
  365
  404
  444
  486
  530
  576
  624
  673
  724
  778
  833
  891
  951
  1,013
  1,078
  1,146
  1,217
  1,291
  1,367
  1,448
Tax expense, $m
  19
  19
  25
  31
  37
  44
  52
  60
  68
  77
  87
  99
  109
  120
  131
  143
  156
  168
  182
  196
  210
  225
  241
  257
  274
  291
  309
  329
  348
  369
  391
Net income, $m
  35
  53
  67
  83
  101
  119
  140
  162
  185
  209
  235
  267
  295
  324
  355
  387
  420
  455
  491
  529
  568
  608
  650
  694
  740
  787
  837
  888
  942
  998
  1,057

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  68
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  541
  569
  676
  793
  921
  1,060
  1,209
  1,367
  1,536
  1,714
  1,901
  2,098
  2,303
  2,518
  2,742
  2,975
  3,217
  3,469
  3,731
  4,003
  4,286
  4,580
  4,886
  5,204
  5,535
  5,879
  6,238
  6,611
  7,000
  7,407
  7,830
Adjusted assets (=assets-cash), $m
  473
  569
  676
  793
  921
  1,060
  1,209
  1,367
  1,536
  1,714
  1,901
  2,098
  2,303
  2,518
  2,742
  2,975
  3,217
  3,469
  3,731
  4,003
  4,286
  4,580
  4,886
  5,204
  5,535
  5,879
  6,238
  6,611
  7,000
  7,407
  7,830
Revenue / Adjusted assets
  1.182
  1.181
  1.182
  1.183
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
  1.182
Average production assets, $m
  89
  107
  127
  149
  173
  199
  227
  257
  289
  322
  357
  394
  433
  473
  515
  559
  605
  652
  701
  752
  806
  861
  918
  978
  1,040
  1,105
  1,172
  1,242
  1,316
  1,392
  1,472
Working capital, $m
  254
  224
  266
  312
  363
  417
  476
  538
  605
  675
  748
  826
  907
  991
  1,079
  1,171
  1,266
  1,365
  1,469
  1,576
  1,687
  1,803
  1,923
  2,048
  2,179
  2,314
  2,455
  2,602
  2,755
  2,915
  3,082
Total debt, $m
  119
  167
  221
  279
  344
  413
  488
  567
  651
  741
  834
  933
  1,036
  1,143
  1,256
  1,372
  1,494
  1,620
  1,751
  1,888
  2,029
  2,177
  2,330
  2,489
  2,655
  2,827
  3,007
  3,194
  3,389
  3,593
  3,805
Total liabilities, $m
  236
  285
  339
  397
  462
  531
  606
  685
  769
  859
  952
  1,051
  1,154
  1,261
  1,374
  1,490
  1,612
  1,738
  1,869
  2,006
  2,147
  2,295
  2,448
  2,607
  2,773
  2,945
  3,125
  3,312
  3,507
  3,711
  3,923
Total equity, $m
  304
  284
  337
  396
  460
  529
  603
  682
  766
  855
  949
  1,047
  1,149
  1,256
  1,368
  1,484
  1,605
  1,731
  1,862
  1,998
  2,139
  2,286
  2,438
  2,597
  2,762
  2,934
  3,113
  3,299
  3,493
  3,696
  3,907
Total liabilities and equity, $m
  540
  569
  676
  793
  922
  1,060
  1,209
  1,367
  1,535
  1,714
  1,901
  2,098
  2,303
  2,517
  2,742
  2,974
  3,217
  3,469
  3,731
  4,004
  4,286
  4,581
  4,886
  5,204
  5,535
  5,879
  6,238
  6,611
  7,000
  7,407
  7,830
Debt-to-equity ratio
  0.391
  0.590
  0.650
  0.710
  0.750
  0.780
  0.810
  0.830
  0.850
  0.870
  0.880
  0.890
  0.900
  0.910
  0.920
  0.920
  0.930
  0.940
  0.940
  0.940
  0.950
  0.950
  0.960
  0.960
  0.960
  0.960
  0.970
  0.970
  0.970
  0.970
  0.970
Adjusted equity ratio
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499
  0.499

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  35
  53
  67
  83
  101
  119
  140
  162
  185
  209
  235
  267
  295
  324
  355
  387
  420
  455
  491
  529
  568
  608
  650
  694
  740
  787
  837
  888
  942
  998
  1,057
Depreciation, amort., depletion, $m
  13
  16
  17
  19
  21
  23
  26
  28
  31
  33
  36
  33
  36
  39
  43
  46
  50
  54
  58
  62
  67
  71
  76
  81
  86
  91
  97
  103
  109
  115
  122
Funds from operations, $m
  8
  68
  84
  102
  122
  143
  165
  190
  215
  242
  271
  299
  331
  363
  398
  433
  470
  509
  549
  591
  634
  679
  726
  775
  826
  879
  934
  991
  1,051
  1,113
  1,178
Change in working capital, $m
  -24
  38
  42
  46
  50
  55
  59
  62
  66
  70
  74
  77
  81
  84
  88
  92
  95
  99
  103
  107
  111
  116
  120
  125
  130
  136
  141
  147
  153
  160
  167
Cash from operations, $m
  32
  30
  42
  56
  71
  88
  107
  127
  149
  172
  197
  222
  250
  279
  310
  342
  375
  410
  446
  484
  523
  564
  606
  650
  696
  743
  792
  844
  898
  953
  1,012
Maintenance CAPEX, $m
  0
  -7
  -9
  -10
  -12
  -14
  -16
  -19
  -21
  -24
  -27
  -30
  -33
  -36
  -39
  -43
  -46
  -50
  -54
  -58
  -62
  -67
  -71
  -76
  -81
  -86
  -91
  -97
  -103
  -109
  -115
New CAPEX, $m
  -12
  -18
  -20
  -22
  -24
  -26
  -28
  -30
  -32
  -33
  -35
  -37
  -39
  -40
  -42
  -44
  -46
  -47
  -49
  -51
  -53
  -55
  -57
  -60
  -62
  -65
  -67
  -70
  -73
  -76
  -80
Cash from investing activities, $m
  -10
  -25
  -29
  -32
  -36
  -40
  -44
  -49
  -53
  -57
  -62
  -67
  -72
  -76
  -81
  -87
  -92
  -97
  -103
  -109
  -115
  -122
  -128
  -136
  -143
  -151
  -158
  -167
  -176
  -185
  -195
Free cash flow, $m
  22
  5
  13
  23
  35
  48
  62
  79
  96
  115
  136
  155
  179
  203
  228
  255
  283
  312
  343
  375
  408
  442
  477
  514
  553
  592
  634
  677
  722
  768
  817
Issuance/(repayment) of debt, $m
  37
  48
  54
  59
  64
  69
  75
  80
  84
  89
  94
  98
  103
  108
  112
  117
  121
  126
  131
  136
  142
  147
  153
  159
  166
  172
  180
  187
  195
  203
  212
Issuance/(repurchase) of shares, $m
  14
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  18
  48
  54
  59
  64
  69
  75
  80
  84
  89
  94
  98
  103
  108
  112
  117
  121
  126
  131
  136
  142
  147
  153
  159
  166
  172
  180
  187
  195
  203
  212
Total cash flow (excl. dividends), $m
  40
  53
  67
  82
  99
  117
  137
  158
  180
  204
  229
  254
  282
  310
  341
  372
  405
  439
  474
  511
  549
  589
  630
  673
  718
  765
  813
  864
  917
  972
  1,029
Retained Cash Flow (-), $m
  -50
  -48
  -53
  -59
  -64
  -69
  -74
  -79
  -84
  -89
  -93
  -98
  -103
  -107
  -112
  -116
  -121
  -126
  -131
  -136
  -141
  -147
  -153
  -159
  -165
  -172
  -179
  -186
  -194
  -203
  -211
Prev. year cash balance distribution, $m
 
  68
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  73
  14
  24
  35
  48
  63
  79
  96
  115
  136
  156
  179
  203
  229
  256
  284
  313
  343
  375
  408
  442
  478
  515
  553
  593
  635
  678
  723
  769
  818
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  70
  12
  21
  29
  37
  46
  53
  60
  66
  71
  74
  76
  77
  77
  75
  72
  68
  63
  58
  52
  46
  40
  34
  28
  23
  19
  15
  11
  8
  6
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations. It markets and distributes its generic prescription and over the counter pharmaceutical products to wholesalers, chain drug stores, distributors, and mass market merchandisers. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals for use in the manufacture of plastics, surface coatings, cosmetics and personal care products, textiles, and fuels and lubricants, as well as for food, flavor, paper, and film industries; dye and pigment intermediates used in the color-producing industries; and organic intermediates used in the production of agrochemicals. Its raw materials are also used in electronic parts for photo tooling, circuit boards, and production of computer chips. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides, which control weed growth and the spread of insects and microorganisms; and sprout inhibitors for potatoes. The company serves various companies in the industrial chemical, agricultural, and human health and pharmaceutical industries primarily in the United States, Europe, and the Asia-Pacific. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York.

FINANCIAL RATIOS  of  Aceto (ACET)

Valuation Ratios
P/E Ratio 12.9
Price to Sales 0.8
Price to Book 1.5
Price to Tangible Book
Price to Cash Flow 14.1
Price to Free Cash Flow 22.6
Growth Rates
Sales Growth Rate 2.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 500%
Cap. Spend. - 3 Yr. Gr. Rate 32%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 39.1%
Total Debt to Equity 39.1%
Interest Coverage 19
Management Effectiveness
Return On Assets 7.2%
Ret/ On Assets - 3 Yr. Avg. 7.4%
Return On Total Capital 8.9%
Ret/ On T. Cap. - 3 Yr. Avg. 9.5%
Return On Equity 12.5%
Return On Equity - 3 Yr. Avg. 13.2%
Asset Turnover 1.1
Profitability Ratios
Gross Margin 25.6%
Gross Margin - 3 Yr. Avg. 24.3%
EBITDA Margin 12.5%
EBITDA Margin - 3 Yr. Avg. 12%
Operating Margin 10.4%
Oper. Margin - 3 Yr. Avg. 9.7%
Pre-Tax Margin 9.7%
Pre-Tax Margin - 3 Yr. Avg. 9.5%
Net Profit Margin 6.3%
Net Profit Margin - 3 Yr. Avg. 6%
Effective Tax Rate 35.2%
Eff/ Tax Rate - 3 Yr. Avg. 36.5%
Payout Ratio 20%

ACET stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the ACET stock intrinsic value calculation we used $559 million for the last fiscal year's total revenue generated by Aceto. The default revenue input number comes from 2016 income statement of Aceto. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our ACET stock valuation model: a) initial revenue growth rate of 20.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for ACET is calculated based on our internal credit rating of Aceto, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Aceto.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of ACET stock the variable cost ratio is equal to 83.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $36 million in the base year in the intrinsic value calculation for ACET stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Aceto.

Corporate tax rate of 27% is the nominal tax rate for Aceto. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the ACET stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for ACET are equal to 15.9%.

Life of production assets of 12.1 years is the average useful life of capital assets used in Aceto operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for ACET is equal to 33.3%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $304 million for Aceto - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 29.977 million for Aceto is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Aceto at the current share price and the inputted number of shares is $0.5 billion.

RELATED COMPANIES Price Int.Val. Rating
PFE Pfizer 33.32 28.58  hold
NVS Novartis ADR 84.29 35.73  str.sell
KWR Quaker Chemica 150.91 63.45  str.sell
MRK Merck&Co 62.57 30.02  str.sell
PBH Prestige Brand 52.17 29.64  sell
VRX Valeant Pharma 17.54 21.86  buy
GSK GlaxoSmithKlin 42.24 96.05  str.buy
CBM Cambrex 59.45 87.99  str.buy

COMPANY NEWS

▶ ACETO to Present at the Singular Summer Solstice Conference   [Jul-07-17 09:00AM  GlobeNewswire]
▶ ETFs with exposure to Aceto Corp. : June 15, 2017   [Jun-15-17 12:53PM  Capital Cube]
▶ ETFs with exposure to Aceto Corp. : June 2, 2017   [Jun-02-17 01:48PM  Capital Cube]
▶ ETFs with exposure to Aceto Corp. : May 23, 2017   [May-23-17 12:23PM  Capital Cube]
▶ Aceto posts 3Q profit   [May-04-17 07:44PM  Associated Press]
▶ Aceto Corp. Value Analysis (NASDAQ:ACET) : April 24, 2017   [Apr-24-17 03:03PM  Capital Cube]
▶ Should You Get Rid of INC Research (INCR) Now?   [Mar-08-17 08:47AM  Zacks]
▶ Top Ranked Value Stocks to Buy for March 6th   [Mar-06-17 09:32AM  Zacks]
▶ Should You Get Rid of Ensign Group (ENSG) Now?   [Mar-03-17 08:42AM  Zacks]
▶ Why Aceto Corporation's Shares Plunged 18% Today   [Feb-03-17 03:26PM  at Motley Fool]
▶ What Smart Money Thinks of Aceto Corporation (ACET)?   [Dec-12-16 06:31PM  at Insider Monkey]
▶ ACETO Board of Directors Declares Quarterly Cash Dividend   [Dec-01-16 02:11PM  GlobeNewswire]
Stock chart of ACET Financial statements of ACET Annual reports of ACET
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.